Dupilumab yields rapid reductions in nasal polyp burden and improvements in smell function; these benefits persist with extended dosing intervals.

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...

One of the most bothersome things about being sick or having seasonal allergies is that it makes your nose stuffy and blocked ...

We know it well: That annoying sensation of mucus dripping down the back of your throat. Whether it happens when you’re getting over a cold or bogged down by spring or fall allergy symptoms, knowing ...